Purchases and Sales Made in Q4 2023 in Sangamo Therapeutics, Inc (SGMO)
This table provides information about the institutional ownership of Sangamo Therapeutics, Inc (SGMO) during Q4 2023. The information is specifically focused on institutions that hold shares of SANGAMO THERAPEUTICS, INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 07, 2024
Q4 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-229K- 28.46% |
$68.6K - $144K
|
575K
$656K
|
|
|
Feb 12, 2024
Q4 2023
|
High Tower Advisors, LLC
Chicago, IL |
SELL
|
- |
-352K- 30.79% |
$106K - $222K
|
791K
$902K
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
SELL
|
- |
-604K- 80.94% |
$181K - $380K
|
142K
$162K
|
|
|
Feb 13, 2024
Q4 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.37M- 84.02% |
$410K - $860K
|
260K
$296K
|
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.7M- 10.77% |
$510K - $1.07M
|
14.1M
$16.1M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-3.3M- 72.84% |
$990K - $2.08M
|
1.23M
$1.4M
|
|
|
Feb 14, 2024
Q4 2023
|
Wasatch Advisors Inc
Salt Lake City, UT |
SELL
|
- |
-5.59M- 31.07% |
$1.68M - $3.52M
|
12.4M
$14.1M
|